Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 6.71%1.96B | ---- | 21.65%1.84B | ---- | 30.19%1.51B | ---- | 24.30%1.16B | ---- | 36.44%935.19M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -10.86%-73.17M | ---- | 17.40%-66M | ---- | 21.45%-79.91M | ---- | 14.38%-101.73M | ---- | -364.49%-118.82M |
| Attributable subsidiary (profit) loss | ---- | -74.80%-4.77M | ---- | -156.84%-2.73M | ---- | 121.92%4.8M | ---- | -23.50%-21.92M | ---- | -8.99%-17.75M |
| Impairment and provisions: | ---- | 6.32%23.6M | ---- | -52.03%22.19M | ---- | 44.84%46.27M | ---- | 26.18%31.94M | ---- | 105.38%25.32M |
| -Impairment of trade receivables (reversal) | ---- | 32.71%24.99M | ---- | -40.11%18.83M | ---- | 38.12%31.44M | ---- | 7.37%22.77M | ---- | 142.49%21.2M |
| -Other impairments and provisions | ---- | -141.46%-1.39M | ---- | -77.32%3.36M | ---- | 61.53%14.83M | ---- | 123.20%9.18M | ---- | 14.80%4.11M |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | 41.87%1.35M | ---- | --953K | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | 41.87%1.35M | ---- | --953K | ---- | ---- |
| Asset sale loss (gain): | ---- | 105.60%39K | ---- | -632.63%-696K | ---- | -150.00%-95K | ---- | 222.03%190K | ---- | 102.31%59K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---779K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -53.01%39K | ---- | 187.37%83K | ---- | -150.00%-95K | ---- | 222.03%190K | ---- | -78.85%59K |
| Depreciation and amortization: | ---- | -0.35%386.71M | ---- | 1.64%388.07M | ---- | 18.50%381.79M | ---- | 211.07%322.19M | ---- | 156.03%103.57M |
| -Depreciation | ---- | -2.01%280.24M | ---- | -0.09%285.99M | ---- | 18.95%286.25M | ---- | 577.99%240.65M | ---- | 5,386.09%35.5M |
| -Amortization of intangible assets | ---- | -1.27%9.89M | ---- | -3.19%10.01M | ---- | -6.07%10.34M | ---- | 48.08%11.01M | ---- | 9.71%7.44M |
| Financial expense | ---- | -4.05%4.5M | ---- | 1.40%4.69M | ---- | -56.18%4.63M | ---- | 119.83%10.56M | ---- | 435.08%4.81M |
| Exchange Loss (gain) | ---- | 144.82%532K | ---- | 95.62%-1.19M | ---- | -405.49%-27.1M | ---- | 130.29%8.87M | ---- | -297.58%-29.29M |
| Special items | ---- | -42.91%21.44M | ---- | 76.18%37.55M | ---- | 338.36%21.31M | ---- | ---8.94M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 4.52%2.32B | ---- | 19.10%2.22B | ---- | 32.88%1.87B | ---- | 55.53%1.4B | ---- | 27.28%903.09M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -103.01%-270K | ---- | -11.61%8.97M | ---- | 13,083.12%10.15M | ---- | 101.80%77K | ---- | -121.63%-4.28M |
| Accounts receivable (increase)decrease | ---- | -83.52%-214.56M | ---- | 86.46%-116.91M | ---- | -54.31%-863.34M | ---- | -10.49%-559.49M | ---- | -148.42%-506.36M |
| Accounts payable increase (decrease) | ---- | -41.41%356.94M | ---- | -29.84%609.23M | ---- | -9.52%868.39M | ---- | 283.51%959.74M | ---- | -3.00%250.25M |
| prepayments (increase)decrease | ---- | -124.34%-6.91M | ---- | 145.16%28.39M | ---- | 77.57%-62.85M | ---- | -120.87%-280.24M | ---- | 8.86%-126.88M |
| Special items for working capital changes | ---- | 124.40%276.26M | ---- | 192.18%123.11M | ---- | -78.60%42.13M | ---- | -18.58%196.88M | ---- | 5.42%241.81M |
| Cash from business operations | -88.42%71.38M | -4.89%2.73B | 134.56%616.61M | 54.54%2.88B | 18.07%-1.78B | 8.09%1.86B | -393.73%-2.18B | 127.23%1.72B | 331.89%741.43M | -13.28%757.63M |
| Other taxs | -43.69%-269.6M | 6.02%-427.72M | 16.95%-187.62M | -19.14%-455.11M | -35.42%-225.92M | -45.95%-381.98M | -52.16%-166.83M | -28.30%-261.73M | -59.95%-109.65M | -14.41%-204M |
| Interest paid - operating | 8.70%-2.08M | 4.05%-4.5M | 4.25%-2.28M | -1.40%-4.69M | -2.41%-2.38M | 56.18%-4.63M | 56.41%-2.32M | -119.83%-10.56M | -1,234.59%-5.33M | -435.08%-4.81M |
| Net cash from operations | -146.94%-200.3M | -4.69%2.3B | 121.20%426.71M | 63.87%2.42B | 14.24%-2.01B | 1.73%1.47B | -474.64%-2.35B | 164.06%1.45B | 509.86%626.46M | -20.97%548.83M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -83.34%9.31M | 14.85%67.06M | 99.58%55.88M | -20.38%58.39M | -14.70%28M | -27.76%73.34M | -45.98%32.83M | -14.65%101.52M | 7.60%60.76M | 316.94%118.95M |
| Dividend received - investment | --2.55M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---1.98B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | 125.71%711K | -23.73%2M | 22.09%315K | 57.23%2.62M | -56.12%258K | 303.63%1.67M | 120.22%588K | -66.91%413K | 456.25%267K | -21.41%1.25M |
| Purchase of fixed assets | -158.75%-44.34M | 13.16%-66.52M | 52.92%-17.13M | -3.36%-76.59M | -19.51%-36.39M | 5.35%-74.1M | 16.27%-30.45M | -26.90%-78.28M | -69.39%-36.37M | -31.81%-61.69M |
| Sale of subsidiaries | ---- | ---- | ---- | --52.53M | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | --5.94M | ---- | ---- | 253.85%6.23M | ---- | 84.85%-4.05M | 82.62%-4.05M | -2,165.17%-26.74M | -2,085.86%-23.31M | 104.92%1.3M |
| Cash on investment | 99.56%-3.72M | ---844.89M | ---842.44M | ---- | ---- | 88.93%-94.69M | 89.14%-92.84M | ---855.21M | ---855.21M | ---- |
| Other items in the investment business | ---- | ---- | ---- | --13.11M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 96.32%-29.54M | -5,107.11%-2.82B | -9,775.57%-803.38M | 157.53%56.29M | 91.34%-8.14M | 88.60%-97.84M | 89.00%-93.93M | -1,535.17%-858.3M | -2,457.57%-853.86M | 1,821.50%59.81M |
| Net cash before financing | 38.98%-229.84M | -120.86%-515.59M | 81.36%-376.67M | 79.61%2.47B | 17.21%-2.02B | 132.92%1.38B | -973.37%-2.44B | -2.91%590.94M | -263.67%-227.41M | -11.91%608.64M |
| Cash flow from financing activities | ||||||||||
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.21%622.1M |
| Dividends paid - financing | ---387K | -87.26%-555.09M | ---- | -72.25%-296.43M | ---1.61M | 28.39%-172.1M | ---- | -18.68%-240.31M | ---- | -26.55%-202.48M |
| Absorb investment income | ---- | -75.00%3.25M | 0.00%2.45M | -33.03%13M | -87.38%2.45M | 340.16%19.41M | --19.41M | -51.70%4.41M | ---- | 17.55%9.13M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -656.89%-88.65M |
| Other items of the financing business | 106.38%1.06M | 81.42%-19.47M | 10.52%-16.58M | -314.31%-104.76M | 59.65%-18.53M | --48.89M | -446.12%-45.91M | ---- | ---8.41M | ---- |
| Net cash from financing operations | 58.94%-12.5M | -44.56%-604.67M | 29.64%-30.44M | -203.94%-418.27M | -10.20%-43.26M | 59.50%-137.62M | 57.90%-39.26M | -212.40%-339.81M | -117.17%-93.25M | -92.52%302.33M |
| Effect of rate | -238.73%-283K | -144.82%-532K | -94.46%204K | -95.59%1.19M | -72.67%3.68M | 410.75%26.92M | 490.92%13.48M | -130.38%-8.66M | -106.31%-3.45M | 285.61%28.52M |
| Net Cash | 40.47%-242.34M | -154.54%-1.12B | 80.28%-407.1M | 65.80%2.05B | 16.78%-2.06B | 393.29%1.24B | -673.47%-2.48B | -72.43%251.13M | -147.01%-320.66M | -80.74%910.97M |
| Begining period cash | -10.18%9.89B | 22.95%11.01B | 22.95%11.01B | 16.46%8.96B | 16.46%8.96B | 3.26%7.69B | 3.26%7.69B | 14.43%7.45B | 14.43%7.45B | 262.89%6.51B |
| Cash at the end | -9.02%9.65B | -10.18%9.89B | 53.78%10.6B | 22.95%11.01B | 32.01%6.9B | 16.46%8.96B | -26.67%5.22B | 3.26%7.69B | -1.68%7.12B | 14.43%7.45B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Tianji International Accounting Firm (Special General Partnership), Tianji Hong Kong Certified Public Accountants Limited | -- | Tianji International Accounting Firm (Special General Partnership), Tianji Hong Kong Certified Public Accountants Limited | -- | Tianji International Accounting Firm (Special General Partnership), Tianji Hong Kong Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.